Insights
What's New
New Complexities and Risk Management Requirements of the Pharma Supply Chain Post-COVID
The pandemic has forced stakeholders including asset owners, financiers, insurers/reinsurers, and brokers to re-assess risks to key facilities across the pharmaceutical and life sciences sector. Entirely new complexities have entered into the pharma supply chain that may require new risk management considerations are put in place. As such, it is more important than ever to…
2020 in review: How Covid-19’s impact on replacement costs played out
Source: John Foord Research In April 2020, as Covid-19 cases were rising around the world, I made a number of observations in a blog post on the pandemic’s potential impact on reinstatement costs. Below, I recap my comments from April 2020 as the world entered the first wave of lockdowns and travel restrictions, and I…
Q&A with Steve Tunstall: Insurance Industry needs a Cloud-based Valuation Alternative
In this blog post, we sat down with Steve Tunstall [ST], Director of Tunstall Associates, to find out more about his background, thoughts on the insurance market, what he thinks of cloud-based analytics technology and the John Foord Analytics platform. [JF]: Can you tell us about your background in the insurance industry? [ST]: I started my…
Q&A with Michael Gallagher, Chairman, John Foord Analytics
In this blog post, we sat down with Michael Gallagher [MG], Chairman of John Foord Analytics, to find out more about his background, why he was excited to join John Foord [JF], the opportunity for cloud-based analytics technology to address insurance industry challenges, how COVID has disrupted the insurance sector, and what he sees ahead…
